Literature DB >> 18189193

Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjögren's syndrome.

H L Ramos1, G Valencia-Pacheco, J Alcocer-Varela.   

Abstract

OBJECTIVE: Signal transducers and activators of transcription (STATs) are crucial mediators of cytokine signalling. Constitutive activation of STATs, especially STAT3, has been reported in several diseases. Primary Sjögren's syndrome (pSS) is associated with overproduction of cytokines such as interleukin-10 (IL-10), although the mechanism by which this occurs is unknown. As STAT3 is a potent inducer of IL-10, this study focused on determining the pattern of STAT3 activation in peripheral lymphocytes from patients with pSS.
METHODS: Twelve pSS patients and 12 healthy age-matched control subjects were studied. Peripheral blood mononuclear cells (PBMCs) were isolated by gradient centrifugation. Phosphorylated STAT3 (pSTAT3) and also STAT3 expression were determined by flow cytometry in gated CD3(+ )and CD19(+) lymphocytes. Similarly, pJak1 and pTyk2 were also determined in gated CD3(+) lymphocytes.
RESULTS: Although the protein expression of STAT3 was similar among controls and pSS patients, we found that STAT3 was constitutively activated in CD3(+) lymphocytes from pSS patients. Neither Jak1 nor Tyk2 (the upstream activators of STAT3) was activated in pSS CD3(+) lymphocytes, suggesting that the constitutive activation of STAT3 observed in pSS patients might not depend on cytokine stimulation but instead might be the result of an abnormal inactivation of pSTAT3.
CONCLUSIONS: These data provide evidence of abnormal STAT3 signalling in T cells from pSS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189193     DOI: 10.1080/03009740701606010

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 2.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

3.  STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.

Authors:  M Pertovaara; O Silvennoinen; P Isomäki
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

4.  Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study.

Authors:  Jani Oiva; Harri Mustonen; Marja-Leena Kylänpää; Lea Kyhälä; Krista Kuuliala; Sanna Siitonen; Esko Kemppainen; Pauli Puolakkainen; Heikki Repo
Journal:  Crit Care       Date:  2010-11-18       Impact factor: 9.097

5.  Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.

Authors:  Ji-Won Kim; Sung-Min Kim; Jin-Sil Park; Sun-Hee Hwang; JeongWon Choi; Kyung-Ah Jung; Jun-Geol Ryu; Seon-Yeong Lee; Seung-Ki Kwok; Mi-La Cho; Sung-Hwan Park
Journal:  Arthritis Res Ther       Date:  2019-06-04       Impact factor: 5.156

6.  Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.

Authors:  Richard Davies; Irene Sarkar; Daniel Hammenfors; Brith Bergum; Petra Vogelsang; Silje M Solberg; Sonia Gavasso; Johan G Brun; Roland Jonsson; Silke Appel
Journal:  Front Immunol       Date:  2019-02-21       Impact factor: 7.561

7.  Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation.

Authors:  Irene Sarkar; Richard Davies; Anders K Aarebrot; Silje M Solberg; Aleksandra Petrovic; Anagha M Joshi; Brith Bergum; Johan G Brun; Daniel Hammenfors; Roland Jonsson; Silke Appel
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

8.  Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.

Authors:  S R Vartoukian; W M Tilakaratne; N Seoudi; M Bombardieri; L Bergmeier; A R Tappuni; F Fortune
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

9.  Gene expression alterations in salivary gland epithelia of Sjögren's syndrome patients are associated with clinical and histopathological manifestations.

Authors:  Ariana Dela Cruz; Vinay Kartha; Andrew Tilston-Lunel; Rongjuan Mi; Taylor L Reynolds; Michael Mingueneau; Stefano Monti; Janicke L Jensen; Kathrine Skarstein; Xaralabos Varelas; Maria A Kukuruzinska
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.